Clinical Trials
2 trialsNCT06126276 2026-06-02
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05556772 2025-12-16
Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic
Fred Hutchinson Cancer Center
Phase NA Active not recruiting